Personal information

Emails & domains

Verified email domains

Other IDs

Researcher Name Resolver ID: 1000090738254
Scopus Author ID: 55578333900

Keywords

Breast Cancer, Obesity, Surgical Oncology

Countries

United States

Activities

Collapse all

Employment (8)

University of Hawai'i Cancer Center: Honolulu, Hawai'i, US

2023-04-16 to present | Assistant professor, Investigator-Initiated Early Phase Clinical Trial Development and Regulatory Director (Translational and Clinical Research | Clinical Trial Office)
Employment
Source: Self-asserted source
Toshiaki Iwase

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2021-11-03 to 2023-04-15 | Clinical Research Instructor, Research Faculty Appointment (Breast Medical Oncology)
Employment
Source: Self-asserted source
Toshiaki Iwase

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2017-01-13 to 2021-11-02 | Clinical Postdoctoral Fellow (Breast Medical Oncology)
Employment
Source: Self-asserted source
Toshiaki Iwase

Chiba University Hospital: Chiba, JP

2016-04-01 to 2017-01-12 | Assistant Professor (Department of General Surgery)
Employment
Source: Self-asserted source
Toshiaki Iwase

Chiba graduate school of Medicine: Chiba, JP

2013-04-01 to 2016-03-31
Employment
Source: Self-asserted source
Toshiaki Iwase

Chiba Cancer Center: Chiba, JP

2011-04-01 to 2013-03-31 (Division of Breast Surgery)
Employment
Source: Self-asserted source
Toshiaki Iwase

Kawasaki Shiritsu Kawasaki Byoin: Kawasaki, Kanagawa, JP

2008-04-01 to 2009-03-31 (Department of Emergency Medicine)
Employment
Source: Self-asserted source
Toshiaki Iwase

Iwata Shiritsu Sogo Byoin: Iwata, JP

2006-04-01 to 2008-03-31
Employment
Source: Self-asserted source
Toshiaki Iwase

Education and qualifications (2)

Chiba Daigaku Daigakuin Igaku Kenkyuin Igakubu: Chiba, Chiba, JP

2013-04-01 to 2016-03-31 | Ph. D.
Education
Source: Self-asserted source
Toshiaki Iwase

Showa Daigaku: Shinagawa-ku, Tokyo, JP

2000-04-01 to 2006-03-31 | M. D.
Education
Source: Self-asserted source
Toshiaki Iwase

Works (34)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines

Biomedicines
2023-02 | Journal article | Author
DOI: 10.3390/biomedicines11030735
Contributors: Xuemei Xie; Jangsoon Lee; Jon A. Fuson; Huey Liu; Toshiaki Iwase; Kyuson Yun; Cori Margain; Debu Tripathy; Naoto T. Ueno
Source: check_circle
Multidisciplinary Digital Publishing Institute

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

PLoS ONE
2021 | Journal article
DOI: 10.1371/journal.pone.0250057
EID:

2-s2.0-85104263202

Part of ISSN: 19326203
Contributors: Chainitikun, S.; Fernandez, J.R.E.; Long, J.P.; Iwase, T.; Kida, K.; Wang, X.; Saleem, S.; Lim, B.; Valero, V.; Ueno, N.T.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer.

Cancers
2021-09-28 | Journal article
DOI: 10.3390/cancers13194839
PMID: 34638323
PMC: PMC8508147
Source: Self-asserted source
Toshiaki Iwase
grade
Preferred source (of 3)‎

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening

Biomedicines
2021-06 | Journal article | Author
DOI: 10.3390/biomedicines9070740
Contributors: Jangsoon Lee; Huey Liu; Troy Pearson; Toshiaki Iwase; Jon Fuson; Alshad Lalani; Lisa D. Eli; Irmina Diala; Debu Tripathy; Bora Lim et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13112650
Contributors: Toshiaki Iwase; Tushaar Vishal Shrimanker; Ruben Rodriguez-Bautista; Onur Sahin; Anjali James; Jimin Wu; Yu Shen; Naoto T. Ueno
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy

Cancers
2021-02 | Journal article | Author
DOI: 10.3390/cancers13040608
Contributors: Toshiaki Iwase; Aaroh Parikh; Seyedeh S. Dibaj; Yu Shen; Tushaar Vishal Shrimanker; Sudpreeda Chainitikun; Kumiko Kida; Maryanne E. Sapon; Onur Sahin; Anjali James et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Body composition and breast cancer risk and treatment: mechanisms and impact.

Breast cancer research and treatment
2021-01-21 | Journal article
DOI: 10.1007/s10549-020-06092-5
PMID: 33475878
Source: Self-asserted source
Toshiaki Iwase
grade
Preferred source (of 2)‎

Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer

Cancer Medicine
2020 | Journal article
DOI: 10.1002/cam4.2780
EID:

2-s2.0-85076732034

Part of ISSN: 20457634
Contributors: Ueno, N.T.; Tahara, R.K.; Fujii, T.; Reuben, J.M.; Gao, H.; Saigal, B.; Lucci, A.; Iwase, T.; Ibrahim, N.K.; Damodaran, S. et al.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

BMC Cancer
2020 | Journal article
DOI: 10.1186/s12885-020-06940-z
EID:

2-s2.0-85084786148

Part of ISSN: 14712407
Contributors: Iwase, T.; Harano, K.; Masuda, H.; Kida, K.; Hess, K.R.; Wang, Y.; Dirix, L.; Van Laere, S.J.; Lucci, A.; Krishnamurthy, S. et al.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer

Breast Cancer Research and Treatment
2020 | Journal article
DOI: 10.1007/s10549-020-05837-6
EID:

2-s2.0-85088631608

Part of ISSN: 15737217 01676806
Contributors: Chainitikun, S.; Long, J.P.; Rodriguez-Bautista, R.; Iwase, T.; Tripathy, D.; Fujii, T.; Ueno, N.T.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

SSRN
2020 | Other
DOI: 10.2139/ssrn.3514759
EID:

2-s2.0-85110421461

Part of ISSN: 15565068
Contributors: Kida, K.; Hess, K.R.; Lim, B.; Iwase, T.; Chainitikun, S.; Valero, V.; Lucci, A.; Le-Petross, C.; Woodward, W.A.; Krishnamurthy, S. et al.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

Cancers
2020-10 | Journal article | Author
DOI: 10.3390/cancers12113105
Contributors: Kumiko Kida; Kenneth R. Hess; Bora Lim; Toshiaki Iwase; Sudpreeda Chainitikun; Vicente Valero; Anthony Lucci; Huong Carisa Le-Petross; Wendy A. Woodward; Savitri Krishnamurthy et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Targeting Signaling Pathways in Inflammatory Breast Cancer

Cancers
2020-09 | Journal article | Author
DOI: 10.3390/cancers12092479
Contributors: Xiaoping Wang; Takashi Semba; Lan Thi Hanh Phi; Sudpreeda Chainitikun; Toshiaki Iwase; Bora Lim; Naoto T. Ueno
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

British Journal of Cancer
2019 | Journal article
DOI: 10.1038/s41416-019-0473-y
EID:

2-s2.0-85066011951

Part of ISSN: 15321827 00070920
Contributors: Lim, B.; Murthy, R.K.; Lee, J.; Jackson, S.A.; Iwase, T.; Davis, D.W.; Willey, J.S.; Wu, J.; Shen, Y.; Tripathy, D. et al.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer.

Breast cancer research and treatment
2019-10-16 | Journal article
DOI: 10.1007/s10549-019-05467-7
PMID: 31620935
Source: Self-asserted source
Toshiaki Iwase
grade
Preferred source (of 2)‎

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.

British journal of cancer
2019-05-17 | Journal article
Part of DOI: 10.1038/s41416-019-0473-y
PMID: 31097774
Source: Self-asserted source
Toshiaki Iwase

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.

Breast cancer research and treatment
2018-06-18 | Journal article
DOI: 10.1007/s10549-018-4853-4
Part of PMID: 29915946
Source: Self-asserted source
Toshiaki Iwase
grade
Preferred source (of 2)‎

Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancer.

Molecular and Clinical Oncology
2017-10-20 | Journal article
Part of DOI: 10.3892/mco.2017.1464
PMID: 29285378
PMC: PMC5740819
Source: Self-asserted source
Toshiaki Iwase

Breast-Conserving Surgery Using Real-Time Virtual Sonography in a Breast Cancer Patient Who Received Neoadjuvant Chemotherapy - ACase Report

Gan to kagaku ryoho. Cancer & chemotherapy
2016 | Journal article
EID:

2-s2.0-85029564226

Part of ISSN: 03850684
Contributors: Sakakibara, J.; Sakakibara, M.; Sangai, T.; Iwase, T.; Nagashima, T.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients

Cancer Medicine
2016 | Journal article
DOI: 10.1002/cam4.571
EID:

2-s2.0-85006213887

Part of ISSN: 20457634
Contributors: Iwase, T.; Sangai, T.; Nagashima, T.; Sakakibara, M.; Sakakibara, J.; Hayama, S.; Ishigami, E.; Masuda, T.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients

Cancer medicine
2016 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery

European Journal of Surgical Oncology
2016 | Journal article
DOI: 10.1016/j.ejso.2016.01.004
EID:

2-s2.0-84961201810

Part of ISSN: 15322157 07487983
Contributors: Shiina, N.; Sakakibara, M.; Fujisaki, K.; Iwase, T.; Nagashima, T.; Sangai, T.; Kubota, Y.; Akita, S.; Takishima, H.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery

European Journal of Surgical Oncology (EJSO)
2016 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Long-Term Outcome of Radiofrequency Ablation Therapy for Breast Cancer

Gan to kagaku ryoho. Cancer & chemotherapy
2015 | Journal article
EID:

2-s2.0-84989773549

Part of ISSN: 03850684
Contributors: Nagashima, T.; Sakakibara, M.; Sangai, T.; Sakakibara, J.; Iwase, T.; Hayama, S.; Ishigami, E.; Masuda, T.; Nakagawa, A.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

The Case of a Patient with Invasive Lobular Carcinoma with Solitary Metastasis in Pectoralis Major Muscle

Gan to kagaku ryoho. Cancer & chemotherapy
2015 | Journal article
EID:

2-s2.0-84989803122

Part of ISSN: 03850684
Contributors: Iwase, T.; Sangai, T.; Sakakibara, M.; Nagashima, T.; Masuda, T.; Ishigami, E.; Hayama, S.; Sakakibara, J.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients

Breast
2014 | Journal article
DOI: 10.1016/j.breast.2013.11.008
EID:

2-s2.0-84899954149

Part of ISSN: 15323080 09609776
Contributors: Iwase, T.; Nakamura, R.; Yamamoto, N.; Yoshi, A.; Itami, M.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients

The breast
2014 | Journal article
Source: Self-asserted source
Toshiaki Iwase

The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patients

Medicine (United States)
2014 | Journal article
DOI: 10.1097/MD.0000000000000269
EID:

2-s2.0-84920120988

Part of ISSN: 15365964 00257974
Contributors: Iwase, T.; Yamamoto, N.; Ichihara, H.; Togawa, T.; Nagashima, T.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patients

Medicine
2014 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Advanced small-cell colon carcinoma: a case report

Journal of medical case reports
2013 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Advanced small-cell colon carcinoma: A case report

Journal of Medical Case Reports
2013 | Journal article
DOI: 10.1186/1752-1947-7-74
EID:

2-s2.0-84875044523

Part of ISSN: 17521947
Contributors: Iwase, T.; Masuda, Y.; Suzuki, T.; Takahashi, O.; Miyazaki, M.
Source: Self-asserted source
Toshiaki Iwase via Scopus - Elsevier

431 The Effects of the Body Mass Index (BMI) on Neo-adjuvant Chemotherapy

European Journal of Cancer
2012 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Abstract P1-01-24: Is the Dye Method Alone Useful for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer? Prospective Analysis of 1081 Patients after SLN Biopsy

Cancer Research
2010 | Journal article
Source: Self-asserted source
Toshiaki Iwase

Changes in Overall Survival Over Time for Patients With de Novo Metastatic Breast Cancer
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (10 reviews for 7 publications/grants)

Review activity for BMC cancer (2)
Review activity for Breast cancer research and treatment. (3)
Review activity for British journal of cancer. (1)
Review activity for Cancer metastasis reviews. (1)
Review activity for Cancers. (1)
Review activity for NPJ breast cancer. (1)
Review activity for World journal of surgical oncology (1)
How many people are using ORCID?